Ubs Asset Management Americas Inc Tarsus Pharmaceuticals, Inc. Transaction History
Ubs Asset Management Americas Inc
- $379 Billion
- Q1 2025
A detailed history of Ubs Asset Management Americas Inc transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 71,220 shares of TARS stock, worth $3.06 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
71,220
Previous 69,826
2.0%
Holding current value
$3.06 Million
Previous $3.87 Million
5.38%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding TARS
# of Institutions
201Shares Held
44.5MCall Options Held
19.9KPut Options Held
7.6K-
Rtw Investments, LP New York, NY3.32MShares$142 Million2.79% of portfolio
-
Black Rock Inc. New York, NY3.27MShares$140 Million0.0% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.61MShares$112 Million6.87% of portfolio
-
Jennison Associates LLC2.49MShares$107 Million0.09% of portfolio
-
Tang Capital Management LLC San Diego, CA2.45MShares$105 Million8.19% of portfolio
About Tarsus Pharmaceuticals, Inc.
- Ticker TARS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,658,500
- Market Cap $1.14B
- Description
- Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...